© 2003 BMJ Publishing Group & Association of Clinical Pathologists
ECHO
Myopathy and an unusual serum antibody point to a defined syndrome
| The first 150 words of the full text of this article appear below. |
A study of patients presenting over three years with syndromes affecting skeletal muscles has found that those with serum antibody to the signal recognition particle (SRP) represent a defined syndrome. Empirical evidence suggests that early corticosteroid treatment may improve muscle strength.
Seven patients had antibodies to SRP but no antibodies linked with other myopathies. Their age range was 3270 years and five were women. In most patients the disease started in the autumn (August-January), and all had similar signs and symptomssevere, rapidly increasing weakness of proximal muscles, leading to disability. Muscle strength was recorded in some proximal muscles as MRC grade 0/5 in five patients and 3/5 in two. The weakness was always greatest in the deltoid and psoas muscles. Sensation was unaffected. Creatine kinase was greatly increased, up to 300025 000 U/l, and active myopathy was confirmed by electromyography.
Biopsy specimens of affected muscles showed active degeneration and regeneration
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
